Recently Dr. Susan Nedorost read an article in a dermatology newsletter that described an association between a diabetes medication and bullous pemphigoid (BP) BP causes formation of blisters also known as bullae at the space between the epidermis and dermis skin layers and results in severe itching.
The article mentioned a medication class that is typically given to patients for treatment of diabetes. These antidiabetic drugs may cause BP, and substituting a different treatment for diabetes can lead to resolution of BP. Stopping a medication to cure disease is always preferable to treating with a drug, as all drugs can have side effects. BP is often treated with immunosuppressive therapies that can increase the risk of serious infection and some cancers. So Dr. Nedorost reached out to the UH Encite Programmers, Stephanie Rancourt and Jesse Preston, to run a query on her patients who were diagnosed with BP and were receiving antidiabetic drugs in this specific class. The query provided Dr. Nedorost and the other clinicians with results that would have taken hours of pulling paper charts to find.
The clinicians then called their patients and worked with the doctors prescribing their diabetic therapies to switch to another treatment. The use of technology and querying existing data sets from our EMR improved patient care.
|About CWRU School of Medicine||Dept of Dermatology||About UHCMC|